Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
about
The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canalMOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA.Life cycle heterogeneity in animal models of human papillomavirus-associated diseasep16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.Our approach to squamous intraepithelial lesions of the uterine cervixThe Utility of p16INK4a and Ki-67 as a Conjunctive Tool in Uterine Cervical Lesions.Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers.Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri.Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma.The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer.p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types.Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.
P2860
Q34278279-DE39F2A5-F72D-4A66-95E8-9F60CF66EEC9Q34289092-FBEF5148-04AF-4633-9071-B87C8681ED78Q34348189-40716ABE-EE13-47F1-AD83-BB1965EBE1EDQ35586592-A34AD358-E7CB-4DFB-95BB-AF77B6294600Q35587773-323BFD25-B6B6-48B4-AA6B-6CF67BD3A441Q36014354-EFD6F744-F60A-494D-99C1-528FBD3987B7Q36343508-87067E10-6353-4A4D-9667-E7EF82932024Q36524778-83B5A440-CA0F-41BC-814D-AA7840889DACQ37406155-4ADD2B3C-1074-4A64-BB0E-631FADF649B4Q37433734-895529C5-F446-441B-A6BA-CA7FA95D0985Q39704018-66D8E347-4D29-48C0-BADF-D01F2C6336D1Q40223298-0E64F8C4-3AF5-4BAF-9055-FE2D089A176DQ52953041-AE5975F1-9327-4146-BBF5-E048DC1D8FB8Q53519290-F63CDF81-8B50-4A5C-8506-3AE30B5A854E
P2860
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@ast
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@en
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@nl
type
label
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@ast
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@en
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@nl
prefLabel
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@ast
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@en
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@nl
P2093
P1476
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
@en
P2093
P356
10.1097/00125480-200103000-00004
P577
2001-03-01T00:00:00Z